Claris Lifesciences has completed the sale of its remaining 20% stake in Otsuka Pharmaceutical India, the joint venture with Otsuka Pharmaceutical Factory, Inc. and Mitsui & Co., to Otsuka Pharmaceutical Factory, Inc. (Japan) for a consideration of $20 million. The agreement to sell was announced on May 8, 2017.
Claris Lifesciences is engaged in manufacturing of drugs and pharmaceutical products. The Company manufactures and markets products across multiple delivery systems, markets and therapeutic segments, including anesthesia and analgesics, blood products, anti-invective's, critical care, and nephrology.
